Back to main

Franklin Templeton’s Ethereum ETF Listing on DTCC: Awaiting SEC Approval

Franklin Templeton’s Ethereum ETF, now listed on the Depository Trust and Clearing Corporation (DTCC) website, awaits SEC approval. Ethereum (ETH) investors have eagerly anticipated the green light for the Spot Ethereum ETF by the US Securities and Exchange Commission (SEC).

More Read

CoinFactiva Furrever Token FURR SOL ETH
Ethereum (ETH) Faces $510M Liquidation Risk, Solana (SOL) Drops 24.03%, and Furrever Token (FURR) Surpasses $1M in Presale
Consensys’s Lawsuit Against SEC: Challenging Gensler’s Authority? Is ETH a security?
Will Furrever Token (FURR) Beat Dogecoin (DOGE)’s 8% Drop and Shiba Inu (SHIB)’s 9% Dip with its 15X ROI Potential?
Unveiling the CZ Mask: Crypto’s Wealthiest Individual Reveals More Than Expected Amid Legal Battle
Can Bitcoin (BTC) Halving’s Impact Last? Solana (SOL) Is On the Rise, Furrever Token (FURR) Steals the Show with 15X ROI

The DTCC listing allows for creation and redemption of the ETF shares but does not guarantee SEC approval for the S-1 filing. While Franklin Templeton submitted its Spot ETH ETF application on February 12, the DTCC listing is a significant step toward ensuring adequate supply adjustment of ETF shares to match market demand, thus helping maintain the ETF’s market price close to its net asset value (NAV).

Historically, the DTCC website has listed securities eligible for trading and settlement post-registration and compliance. The SEC delayed its decision on Franklin Templeton’s Ethereum ETF application until June 11, extending the review period by 45 days. ETF analysts estimate the SEC approval likelihood at 30%.

As of the time of writing, ETH is priced at $3,310.64, showing a 4,4% 7-days growth.

The post Franklin Templeton’s Ethereum ETF Listing on DTCC: Awaiting SEC Approval appeared first on

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Read on CoinFactiva Investment Disclaimer